ARCHIVES

FDA Breakthrough Designation Granted to Pfizer’s Palbociclib

This article is from The Cancer Letter archive.

Vol. 36 No. 4 | April 26, 2013

Download PDF Visit The Full Archive

Related Articles

ODAC Supports Approval For Taxotere In Breast Cancer, Hycamtin In Lung Cancer

June 5, 1998

No Benefit To Kidney Removal For Elderly With Kidney Cancer

May 28, 2010

In Brief: ACS to Spend Record $85 Million On Research: AACR To Honor Hanafusa, DeVita, Barbacid

March 14, 1986

Obey Insists NCI Pressured IARC Into Softening Report On Benzene Risk

August 20, 1982

LeMaistre To Retire As M.D. Anderson President In 1996

August 18, 1995

Blacks Less Likely To Receive Standard Radiation Therapy

October 31, 2008